Theracryf Plc (AIM:TCF)
London · Delayed Price · Currency is GBP · Price in GBX 0.1705
-0.0045 (-2.57%)
Oct 16, 2026, 4:29 PM GMT
Theracryf Market Cap
Theracryf has a market cap or net worth of 4.66 million as of October 16, 2026. It is the 43,908th most valuable company in the world and the 995th biggest in the United Kingdom. Its market cap has increased by 4.17% in one year.
Market Cap
4.66M
Enterprise Value
3.13M
Revenue
n/a
Global Rank
Country Rank
#995 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since October 21, 2015, Theracryf's market cap has decreased from 25.60M to 4.66M, a decrease of -81.80%. That is a compound annual growth rate of -14.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 4.66M | 8.39% |
| Dec 31, 2025 | 4.30M | 90.55% |
| Dec 31, 2024 | 2.26M | -48.72% |
| Dec 29, 2023 | 4.40M | -64.04% |
| Dec 30, 2022 | 12.23M | -13.59% |
| Dec 31, 2021 | 14.16M | -0.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aptamer Group | 11.23M |
| Thalia Therapeutics | 11.10M |
| Genflow Biosciences | 10.20M |
| Solvonis Therapeutics | 7.83M |
| CRISM Therapeutics | 6.93M |
| Cizzle Biotechnology Holdings | 5.95M |
| OptiBiotix Health | 5.84M |
| Futura Medical | 3.41M |